Healthcare & Life Sciences
Repron Therapeutics
Italy
series-c-plus
series-c-plus
Stage
2
Investors
About
Repron Therapeutics develops therapeutics aimed at silencing transcription factors of oncogenes to treat cancer by targeting transcriptional regulators implicated in oncogenesis.
Explore Repron Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.